| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5690731 | Gynecologic Oncology | 2016 | 6 Pages |
Abstract
Extended follow-up of PLCO indicated no mortality benefit from screening for ovarian cancer with CA-125 and TVU.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Paul F. Pinsky, Kelly Yu, Barnett S. Kramer, Amanda Black, Saundra S. Buys, Edward Partridge, John Gohagan, Christine D. Berg, Philip C. Prorok,